Repatha (evolokumab)

The first approved PCSK9 inhibitor in the EU, delivering a consistent, intensive LDL-C reduction1,2

Kontakt oss

Amgen Norge

Amgen Norge
Munkedamsveien 45F
0250 Oslo
Norway
23 30 80 00
www.amgen.no

See all of our office locations here.